Gloria Pharmaceuticals
closedHarbin Gloria Pharmaceuticals is engages in the research, development, production, and sale of pharmaceutical products.
Launch date
Employees
Market cap
CAD791m
Enterprise valuation
CAD731m (Public information from Sep 2024)
Share price
CNY1.84 002437.SZ
Harbin Heilongjiang (HQ)
Financials
Estimates*
| CNY | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|
| Revenues | - | - | 5.1b | 3.1b | 3.1b | 3.1b | 2.6b |
| % growth | - | - | - | (40 %) | 3 % | (1 %) | (16 %) |
| EBITDA | - | - | 502m | 934m | 301m | 18.5m | 340m |
| % EBITDA margin | - | - | 10 % | 31 % | 10 % | 1 % | 13 % |
| Profit | - | - | (2.7b) | 400m | 45.0m | (291m) | 120m |
| % profit margin | - | - | (53 %) | 13 % | 1 % | (9 %) | 5 % |
| EV / revenue | - | - | 1.6x | 2.5x | 2.0x | 1.9x | 2.1x |
| EV / EBITDA | - | - | 16.0x | 8.0x | 21.4x | 310.8x | 16.1x |
| R&D budget | - | - | 186m | 125m | 97.7m | 101m | 85.4m |
| R&D % of revenue | - | - | 4 % | 4 % | 3 % | 3 % | 3 % |
| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | N/A | IPO | |
| Total Funding | - | ||
Recent News about Gloria Pharmaceuticals
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.
ACQUISITION by Otsuka Pharmaceutical Dec 2020
